Relay Therapeutics Inc
(RLAY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 124,287 | 143,736 | 151,794 | 280,119 | 447,646 |
| Marketable Securities | 657,036 | 606,350 | 847,123 | 677,954 | 230,415 |
| Receivables | N/A | N/A | 306 | 403 | 75,000 |
| Other current assets | 10,533 | 3,315 | 8,172 | 6,301 | 7,654 |
| TOTAL | $809,204 | $770,103 | $1,019,505 | $976,242 | $770,100 |
| Non-Current Assets | |||||
| PPE Net | 5,911 | 10,901 | 11,634 | 6,543 | 6,250 |
| Intangibles | 2,300 | 2,300 | 2,300 | 2,300 | 0 |
| Other Non-Current Assets | 53,881 | 60,676 | 66,332 | 23,358 | 23,479 |
| TOTAL | $62,092 | $73,877 | $80,266 | $32,201 | $29,729 |
| Total Assets | $871,296 | $843,980 | $1,099,771 | $1,008,443 | $799,829 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,097 | 9,211 | 10,578 | 8,276 | 6,351 |
| Accrued Expenses | 21,236 | 14,890 | 22,703 | 13,557 | 5,760 |
| Other current liabilities | 1,990 | 1,204 | 26,152 | 396 | N/A |
| TOTAL | $50,729 | $30,269 | $63,709 | $24,321 | $13,632 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 7,679 | N/A | N/A | 248 | N/A |
| Other Non-Current Liabilities | 42,775 | 61,708 | 85,844 | 86,314 | 22,904 |
| TOTAL | $42,775 | $61,708 | $85,844 | $86,314 | $22,904 |
| Total Liabilities | $93,504 | $91,977 | $149,553 | $110,635 | $36,536 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 169,522 | 131,179 | 121,385 | 108,280 | 90,400 |
| Common Shares | 168 | 127 | 121 | 109 | 90 |
| Retained earnings | -1,738,290 | -1,400,582 | -1,058,609 | -768,100 | -404,228 |
| Other shareholders' equity | -991 | -196 | -10,420 | -1,088 | 64 |
| TOTAL | $777,792 | $752,003 | $950,218 | $897,808 | $763,293 |
| Total Liabilities And Equity | $871,296 | $843,980 | $1,099,771 | $1,008,443 | $799,829 |